2014 Data Topical Treatment 
CannaMD
NOVEMBER 22, 2020
Unfortunately, most traditional pharmaceutical options are distinctly lacking due to side effects, as well as a bit of trepidation (although Botox, one current treatment option for migraines, has gained popularity). Patients used the app, Strainprint, which allowed data to be archived and studied. and migraine severity by 49.6%.
Canna Care Docs
DECEMBER 16, 2020
It would feel like an out-of-body experience, except for one fact: your body is constantly reminding you of those symptoms you’ve been suffering from all this time, putting treatment on the back burner while you deal with life as we know it. Research is ongoing, but the existing data and anecdotal reports show potential.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 10, 2022
For instance, an ongoing clinical trial, initiated in April 2021, analyzing the utilization of products, such as THCV, CBDV, and CBD-rich hemp oil, on the treatment of androgenetic Alopecia. Key Topics Covered: Chapter 1 Methodology and Scope. List To Data Sources. Opportunity Analysis (2014-2020-2028). Market Definition.
PrestoDoctor
SEPTEMBER 6, 2023
Opioid Use Reduction : A study published in the journal JAMA Internal Medicine in 2014 found that states in the United States with medical cannabis laws had a significantly lower rate of opioid overdose deaths compared to states without such laws. Individualized Treatment : Cannabis allows for a more personalized approach to pain management.
Cannabis Law Report
JULY 24, 2022
The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 billion by 2029.
Veriheal
JANUARY 5, 2022
Young and Joyce’s letter places a lot of importance on being able to benefit from the therapeutic properties of cannabis as well as being able to get better—and more—data. Young’s Trail of Cannabis Reform. The pair conclude their letter by stating: “We can appreciate when leaders come from different concerns and priorities.
Cannabis Law Report
APRIL 12, 2019
Being of European descent it is a privilege to be updating Europe on such an exciting topic. We aim to continue to do more for the Canadian patients who choose to use medical cannabis as a treatment option. I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep.
Expert insights. Personalized for you.
116 
Let's personalize your content